FMI
AZN icon

F/M Investments’s AstraZeneca AZN Stock Holding History

F/M Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,574
Closed -$1.55M – 401
2025
Q1 		$1.55M Sell
10,574
-467
-4% -$67.6K 0.06% 259
2024
Q4 		$1.45M Buy
11,041
+2,308
+26% +$323K 0.05% 263
2024
Q3 		$1.36M Sell
8,733
-971
-10% -$157K 0.04% 242
2024
Q2 		$1.51M Buy
+9,704
New +$1.46M 0.05% 233

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

F/M Investments's AZN Position: Q2 2025 in Review

F/M Investments sold out of AstraZeneca (AZN) in Q2 2025, closing a stake of 10,574 shares — an estimated $1.55M sold.

F/M Investments first reported a position in AZN in Q2 2024 and held it in 4 quarters. The position peaked at $1.55M in Q1 2025. 1,223 funds tracked by Wall St. Rank hold AZN as of Q2 2025.

  • F/M Investments reported no remaining AstraZeneca position as of Q2 2025 after selling out during the quarter.
  • F/M Investments sold 10,574 AstraZeneca shares in Q2 2025, an estimated $1.55M.
  • F/M Investments first reported a position in AstraZeneca in Q2 2024 and held it in 4 quarters.
  • F/M Investments's AstraZeneca position peaked at $1.55M in Q1 2025.
  • 1,223 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2025.

Based on F/M Investments's 13F filing for Q2 2025, filed 13 Aug 2025.